Equities

Promimic AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Promimic AB

Actions
  • Price (EUR)1.14
  • Today's Change-0.025 / -2.15%
  • Shares traded--
  • 1 Year change-37.53%
  • Beta0.3276
Data delayed at least 15 minutes, as of Feb 11 2026 11:32 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Promimic AB is a Sweden-based biomaterial company. The Company manufactures, markets and sells biomaterials for improved osseointegration (bone healing) to the companies in the markets for orthopedic and dental implants. The Company operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets.

  • Revenue in SEK (TTM)45.57m
  • Net income in SEK-12.13m
  • Incorporated2004
  • Employees18.00
  • Location
    Promimic ABEntreprenorsstraket 10MOELNDAL 431 53SwedenSWE
  • Phone+46 31160860
  • Websitehttps://promimic.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.